Saturday, August 1, 2009

Regulatory Update: Mepolizumab For The Treatment Of Hypereosinophilic Syndrome (HES)

GSK announced that it has notified the European Medicines Agency of its decision to withdraw the Marketing Authorisation Application (MAA) in the EU for mepolizumab for the treatment of hypereosinophilic syndrome (HES). Complete news at...

Thursday, July 30, 2009

Ultrasound Predicts Cardiovascular Risk After Ischemic Attack

Ultrasound can be used to determine a patient's heart risk after a transient ischemic attack (TIA). An evaluation of transcranial (TCD) and extracranial (ECD) Doppler ultrasonography, published in the open access journal BMC Medical Imaging, has shown that both future stroke and future cardiovascular ischemic events can be predicted by abnormal findings. Cardiovascular disease is the major cause of death on long-term follow-up after a TIA. Dr. More at...

Tuesday, July 28, 2009

Media Advisory: Lack Of Rules For Genetic Testing Akin To Wild, Wild West, According To Stanford Podcast

Media Advisory: Lack Of Rules For Genetic Testing Akin To Wild, Wild West, According To Stanford Podcast
With just $399 and a bit of saliva in a cup, consumers can learn about their genetic risk for diseases from breast cancer to Alzheimer's. Now, thanks to social networking sites set up by personal genomics companies, they can also share that information with family, friends and even strangers on the Internet. Bonding over similar genetic background sounds relatively harmless.